stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Latigo Biotherapeutics, Inc. Common StockLTGO
$13.513.15%-0.44

Latigo Biotherapeutics, Inc. Common Stock (LTGO)

Date: 2026-11-02 16:00O: 14.03H: 15.02L: 13.26C: 13.51Vol: 290.1k
Latigo Biotherapeutics, Inc. Common Stock stock is traded at $13.51, with a volume of 290,064. It is down -3.15% in the last 24 hours and down -15.03% over the past month.
Previous Close:
$13.95
Open:
$14.03
24h Volume:
290,064
Relative Volume:
1.66
Market Cap:
$895.70M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.18%
1M Performance:
-15.03%
6M Performance:
0.00%
1Y Performance:
0.00%
1-Day Range:
$0.00$0.00
1-Week Range:
$13.26$16.74
52-Week Range:
$13.26$25.93

Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Company Profile

Name
Latigo Biotherapeutics, Inc. Common Stock
Phone
-
Address
USA
Employee
-
X
-
Next Earnings Date
2026-12-03
Latest SEC Filings
SEC
LTGO's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Upgrades & Downgrades

DateActionAnalystRating Change
Sep-01-26InitiatedGoldmanBuy
Sep-01-26InitiatedGuggenheimBuy
Sep-01-26InitiatedJefferiesBuy
Sep-01-26InitiatedLeerink PartnersOutperform

Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Financials Data

There is no financial data for Latigo Biotherapeutics, Inc. Common Stock (LTGO). Check out other stocks for more information.

Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Insider Trading

  • Director
    Transaction
    Buy
    Cost
    $18.00
    #Shares
    140,000
    Value ($)
    2,520,000
    #Shares Total
    2,008,024
  • 10% Owner
    Transaction
    Buy
    Cost
    $18.00
    #Shares
    140,000
    Value ($)
    2,520,000
    #Shares Total
    2,008,024
Insider TradingRelationshipDateTransactionCost#SharesValue ($)#Shares Total
Tananbaum James B.DirectorAug 10 '26Buy$18.00140,0002,520,0002,008,024
Foresite Capital Management V,10% OwnerAug 10 '26Buy$18.00140,0002,520,0002,008,024

Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Latest News

Oct 29, 2026
Oct 29, 2026
Oct 21, 2026
Oct 21, 2026
Oct 15, 2026
Oct 15, 2026
Oct 01, 2026
Oct 01, 2026
Sep 28, 2026
Sep 28, 2026
Sep 28, 2026
Sep 28, 2026
Sep 24, 2026
Sep 24, 2026
Sep 03, 2026
Sep 03, 2026
Sep 01, 2026
Sep 01, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 09, 2026
Aug 09, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Jul 28, 2026
Jul 28, 2026
Jul 20, 2026
Jul 20, 2026
Jul 17, 2026
Jul 17, 2026

Similar to LTGO